2015 ACR/ARHP Annual Meeting

November 6-11, 2015. San Francisco, CA.

View by Number View by Title View Sessions

View by Date

Sunday, November 8, 2015

2:30PM-4:00PM: Abstract Number: 947

Cohesin Complex Is a New Myositis Autoantigen

Muscle Biology, Myositis and Myopathies I

2:30PM-4:00PM: Abstract Number: 951

Comparative Effectiveness of Tai Chi Versus Physical Therapy in Treating Knee Osteoarthritis: A Randomized, Single-Blind Trial

Osteoarthritis - Clinical Aspects: Treatments and Epidemiology

2:30PM-4:00PM: Abstract Number: 978

Continuous Versus on Demand Treatment of Ankylosing Spondylitis with Diclofenac over 2 Years Does Not Prevent Radiographic Progression of the Spine: Results from a Randomized Prospective Multi-Center Trial

Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Treatment of AS

2:30PM-4:00PM: Abstract Number: 952

Cost-Effectiveness of Opioids for the Treatment of Knee Osteoarthritis: Impact of Chronic Opioid Use on Total Knee Arthroplasty Outcomes

Osteoarthritis - Clinical Aspects: Treatments and Epidemiology

2:30PM-4:00PM: Abstract Number: 965

Crystal Structure of Porphyromonas Gingivalis peptidylarginine Deiminase: Implications for Autoimmunity in Rheumatoid Arthritis

Rheumatoid Arthritis - Human Etiology and Pathogenesis I

2:30PM-4:00PM: Abstract Number: 915

Defining Pain for Fibromyalgia Criteria: Multi-Site or Widespread? an Analysis of Data from Four UK Population-Based Studies

Fibromyalgia: Insights Into Diagnostic Criteria and Symptom Epidemiology

2:30PM-4:00PM: Abstract Number: 933

DEK-Targeting DNA Aptamers As Novel Therapeutics for Inflammatory Arthritis

Innate Immunity and Rheumatic Disease

2:30PM-4:00PM: Abstract Number: 943

Development of an Internationally Agreed Minimal Dataset for Juvenile Dermatomyositis (JDM) for Clinical and Research Use

Muscle Biology, Myositis and Myopathies I

2:30PM-4:00PM: Abstract Number: 926

Development of an Ultrasound Joint Inflammation Score for Rheumatoid Arthritis through a Data-Driven Approach

Imaging of Rheumatic Diseases I: Ultrasound

2:30PM-4:00PM: Abstract Number: 999

Development of Quality Indicators for Hip and Knee Arthroplasty Rehabilitation

ARHP I: Exemplary Abstracts

2:30PM-4:00PM: Abstract Number: 906

Distinct Expression of IL-36Î±, β, Î³ and Their Antagonists IL-36Ra and IL-38 in Psoriasis, Rheumatoid Arthritis and Crohn’s Disease

Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis

2:30PM-4:00PM: Abstract Number: 929

Diurnal Variation of Power Doppler in Metacarpophalangeal Joints of Patients with Rheumatoid Arthritis

Imaging of Rheumatic Diseases I: Ultrasound

2:30PM-4:00PM: Abstract Number: 957

Double Blind Placebo Controlled Randomized Trial of Probiotics in Enthesitis-Related-Arthritis Category of JIA: Effect on Clinical and Immunological Parameters

Pediatric Rheumatology - Clinical and Therapeutic Aspects I: Juvenile Idiopathic Arthritis

2:30PM-4:00PM: Abstract Number: 989

Economic Evaluation of Lupus Nephritis in an International Inception Cohort: Comparing the Hospitalization, Medication, Dialysis, and Procedure Costs of Those with and without Nephritis

Systemic Lupus Erythematosus - Clinical Aspects and Treatment I: Epidemiology and Prognosis

2:30PM-4:00PM: Abstract Number: 963

Ectopic Lymphoid Tissue in the Lung Is Associated with Serum Rheumatoid Arthritis-Related Autoantibodies Even in Absence of Clinically Apparent Rheumatoid Arthritis

Rheumatoid Arthritis - Human Etiology and Pathogenesis I

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].